GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enwei Pharmaceutical Co Ltd (SZSE:301331) » Definitions » Ending Cash Position

Enwei Pharmaceutical Co (SZSE:301331) Ending Cash Position : ¥453.4 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Enwei Pharmaceutical Co Ending Cash Position?

Enwei Pharmaceutical Co's Ending Cash Position for the quarter that ended in Jun. 2024 was ¥453.4 Mil.

Enwei Pharmaceutical Co's quarterly Ending Cash Position declined from Dec. 2023 (¥235.8 Mil) to Mar. 2024 (¥220.7 Mil) but then increased from Mar. 2024 (¥220.7 Mil) to Jun. 2024 (¥453.4 Mil).

Enwei Pharmaceutical Co's annual Ending Cash Position increased from Dec. 2021 (¥64.3 Mil) to Dec. 2022 (¥341.2 Mil) but then declined from Dec. 2022 (¥341.2 Mil) to Dec. 2023 (¥235.8 Mil).

Enwei Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Enwei Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enwei Pharmaceutical Co Ending Cash Position Chart

Enwei Pharmaceutical Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial 47.42 63.02 64.25 341.23 235.82

Enwei Pharmaceutical Co Quarterly Data
Dec17 Dec18 Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 328.18 324.47 235.82 220.69 453.41

Enwei Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Enwei Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=341.232+-105.415
=235.8

Enwei Pharmaceutical Co's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=220.687+232.726
=453.4

Enwei Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Enwei Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Enwei Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enwei Pharmaceutical Co Ltd (SZSE:301331) » Definitions » Ending Cash Position
Comparable Companies
SZSE:002693 SZSE:300584 SZSE:300534 SZSE:301111 SZSE:002365 BJSE:830946 SZSE:000153 SHSE:600513 SHSE:688117 SHSE:600080 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Chuangye Avenue, Enwei Building, Economic Development Zone, Aba District, Tibet Autonomous Region, Changdu, CHN, 854000
Website
http://www.enwei.com.cn
Enwei Pharmaceutical Co Ltd is engaged in the research and development, production and sales of proprietary Chinese medicines and chemical medicines.

Enwei Pharmaceutical Co Headlines

No Headlines